Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06223672 · ClinicalTrials.gov registry record · NA
Essential Fats For Enhancing Cognitive Thinking (EFFECT) Study
A NA study of Cognitive Impairment and Cognitive Decline, sponsored by Ohio State University.
- Recruiting
- Registry status
- NA
- Development phase
- 88
- Enrollment target
- 1
- Study location
NCT06223672: Recruiting NA study of Cognitive Impairment and Cognitive Decline, sponsored by Ohio State University.
NCT06223672 is a NA study of Cognitive Impairment and Cognitive Decline that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 88 participants, below the 665-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06223672, a NA study of Cognitive Impairment and Cognitive Decline, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed research is a randomized crossover trial designed to assess changes in postprandial cognitive function and the gut-brain axis in adults with subjective cognitive complaints who consume 1 study snack per day for 1 week.
Primary Outcome
To determine the impact of consuming the study dietary fats as part of a high fat meal on postprandial cognitive function
Conditions Studied
Interventions
- OTHER Walnuts
- OTHER Simply White Diary-free chocolate bar
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2024-02-07 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What NCT06223672 shows while recruiting
NCT06223672 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 665-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which Walnuts is the first listed.
NCT06223672 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06223672 about?
NCT06223672 is a clinical study titled "Essential Fats For Enhancing Cognitive Thinking (EFFECT) Study". The proposed research is a randomized crossover trial designed to assess changes in postprandial cognitive function and the gut-brain axis in adults with subjective cognitive complaints who consume 1 study snack per day for 1 week.
What is the current status of trial NCT06223672?
This trial is currently recruiting. It is a NA study. The enrollment target is 88 participants. The study started on 2024-02-07. Estimated completion is 2026-05-31.
What conditions does trial NCT06223672 study?
This clinical trial studies the following conditions: Cognitive Impairment, Cognitive Decline.
What interventions are being tested in trial NCT06223672?
The interventions under investigation include: Walnuts (OTHER), Simply White Diary-free chocolate bar (OTHER).
Who is sponsoring clinical trial NCT06223672?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06223672 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06223672's enrollment target sits among peer trials
88 50th of 105 higher than 56 of 105 other Cognitive Impairment trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
RECRUITING · NA
-
Mind Your Heart-II
RECRUITING · NA
-
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
RECRUITING · NA
-
Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study
RECRUITING · NA
-
Amygdala Memory Enhancement
RECRUITING · NA
-
Train Your Brain SC: Exercise for People With Mild-moderate Cognitive Impairments
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI